At Twist Bioscience, our expertise is synthetic DNA. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/27/14 | $31,100,000 | Series B |
ARCH Venture Partners Paladin Capital Group TAO Ventures Yuri Milner | undisclosed |
| 06/11/15 | $37,000,000 | Series C |
ARCH Venture Partners Fidelity Management & Research Company Foresite Capital Management Illumina, Inc Joby Pritzker Nicholas Pritzker Paladin Capital Group Yuri Milner | undisclosed |
| 06/15/17 | $27,000,000 | Series E |
3W Partners Capital Bay City Capital Biomatics Capital  Ditch Plains Capital Management KANGMEI Group NFT Investment Limited Reinet Fund S.C.A | undisclosed |
